A subsidiary of Tilray Brands (TSX:TLRY), Tilray Medical, has recently introduced Redecan-branded medical cannabis in Australia. The initial product offerings include Redecan THC28 Purple Churro and Redecan THC28 Space Age Cake, both available in 15 g packages.
Tilray Brands operates as a global cannabis and consumer packaged goods company, supporting over 40 brands in more than 20 countries. The company’s stock performance has seen a decline of 27.76% year-over-year and 87.35% since 2019.
The expansion of Redecan-branded medical cannabis in Australia underlines Tilray’s commitment to providing high-quality medical cannabis products to patients worldwide. The introduction of Redecan complements the existing medical cannabis portfolio of Tilray and Broken Coast, further empowering patients and healthcare practitioners to find optimal therapeutic solutions.
Tilray Medical, known for its EU-GMP-certified cannabis production facilities in Portugal and Germany, was one of the first licensed producers of medical cannabis in Canada. Tilray Brands, on the other hand, operates as a global cannabis and consumer packaged goods company with a presence in more than 20 countries.
As of the latest trading data, Tilray stock (TSX:TLRY) is trading at C$2.48 per share, with a marginal increase of 0.2%. The stock has shown a decline of 27.76% year-over-year and 87.35% since 2019.
For further discussion and insights on Redecan’s expansion into Australia, investors can join the conversation on Tilray Brands Inc. Bullboard and explore other discussions on Stockhouse’s stock forums and message boards. It is important to note that the information provided in this article is for informational purposes only and should not be construed as investment advice. To view the full disclaimer information, please click here.
(Photo source: Tilray Brands)
